
PDE9-IN-1
CAS No. 2305087-92-5
PDE9-IN-1( —— )
Catalog No. M26362 CAS No. 2305087-92-5
PDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 205 | Get Quote |
![]() ![]() |
10MG | 320 | Get Quote |
![]() ![]() |
25MG | 531 | Get Quote |
![]() ![]() |
50MG | 773 | Get Quote |
![]() ![]() |
100MG | 1062 | Get Quote |
![]() ![]() |
500MG | 2133 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePDE9-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).
-
DescriptionPDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).(In Vivo):In the Unilateral common carotid artery occlusion (UCCAO) mouse model, PDE9-IN-1 (2.5-5.0 mg/kg; orally) significantly reduces the day 6 escape latency time, increases the frequency of platform area crossings, and recoveres learning and memory function. High dose group possibly improved the escape latency time of mice.
-
In VitroPDE9-IN-1 is excellent selectivity across PDE families.
-
In VivoPDE9-IN-1 (2.5 and 5.0 mg/kg; Oral administration; daily for 21 days) effectively recovers learning and memory function. Animal Model:Unilateral common carotid artery occlusion (UCCAO) mouse model Dosage:2.5 and 5.0 mg/kg Administration:Oral administration; daily for 21 days Result:Significantly reduced the day 6 escape latency time and increased the frequency of platform area crossings, and recovered learning and memory function. High dose group possibly improved the escape latency time of mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNMDA receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2305087-92-5
-
Formula Weight362.409
-
Molecular FormulaC17H23FN6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (275.94 mM)
-
SMILESC[C@@H](Nc1nc2n(ncc2c(=O)[nH]1)C1CCCC1)C(=O)N1CC[C@H](F)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lozovaya N, Gataullina S, et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nat Commun. 2014 Aug 1;5:4563.
molnova catalog



related products
-
Ethanolamine hydroch...
Ethanolamine, a viscous, hygroscopic amino alcohol with an ammoniacal odor, is widely distributed in biological tissue and is a component of lecithin.
-
RNAIII-inhibiting pe...
RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus.
-
1-Methyluric acid
1-Methyluric acid acts on the urinary bladder mucosa and increases blood glucose, triglyceride, insulin, and cholesterol levels.